Society For Neuroscience

Listen to our product showcase, view our posters and meet our team!

Come and visit the team at our booth number #1545 to discuss how bit.bio offers partnering opportunities that affords access to the most relevant parental human cell types and corresponding disease models. These models are physiologically relevant and highly characterised, offering predictive, in vitro, human cells for early drug discovery, phenotypic screening, and high-content imaging applications.  

Panel Discussion | Monday 7th October 2:30 PM EST | Located Product Theatre #2, 1500 Aisle (Exhibit Hall)

"Tackling the reproducibility crisis: the need for standardised human cell models for neuroscience research, drug discovery, and therapies."

• Dr Nicole Polinski, Director of Research Programs, The Micael J Fox Dr Foundation for Parkinson's Research
• Dr Phil Mitchell, Director of Integrated Biology, Charles River Laboratories
• Dr Paul Morrill, Chief Business Officer, bit.bio

This panel will explore how standardising human iPSC-derived cells can address the reproducibility crisis in neuroscience, potentially transforming research outcomes through enhanced consistency, improved reproducibility, andå streamlined regulatory compliance across drug discovery and therapeutic development.

Posters

• "Harnessing CRISPR-Ready ioGlutamatergic Neurons and ioMicroglia for drug discovery in neurodegenerative diseases"
  Presented by Ann Byrne | Business Development Manager, Functional Genomics
  Abstract Control Number: 4748
  Session Number: PSTR195
  Session Title: Molecular, Genetic, and Chemogenetic Tools for Neuronal Tagging
  
  
• "Modelling neurodegeneration using a human genetically matched system: a next generation approach to study frontotemporal dementia and amyotrophic lateral sclerosis"
  Presented by Timothy Smith | Associate Director of Sales - North America
  Abstract control number: 9727
  Session Number: PSTR064
  Session title: ALS iPSC Models
  Day & time: 6th Oct 24 08:00-12:00
  
  
• "A scalable and well defined human CNS co-culture platform, suitable for studying excitatory/inhibitory neuron imbalances and the discovery of drugs to treat associated diseases"
  Presenter TBC
  Session Number: PSTR311
  Session Title: Electrophysiological Recording of Neurons and Neural Networks
  
  
• "Physiologically relevant media unmasks severe mitochondrial dysfunction in a deterministically programmed iPSC-derived model of Huntington’s disease"
  Presented by Corey Monteith | Senior Account Manager - Northwest America and Japan
  No:7931
  Session Number: PSTR331
  Session Title: Huntington’s Disease: Molecular and Cellular Mechanisms in Mouse Models
  Session Day and Time: 10/8/2024 1:00:00 PM-10/8/2024 5:00:00 PM
  
  
• "Rapid and consistent generation of human iPSC-derived oligodendrocyte-like cells using opti-ox technology"
  Presented by Brittany Haugen | Account Manager
  Presenter at Poster: Sun, 6 Oct, 10-11am
  Session time: Oct. 6, 2024, 8:00 AM - 12:00 PM
  Control number:  2024-LBA-13669-SfN
  
  
• "Driving experimental reproducibility and lot-to-lot biological consistency in human iPSC-derived cells enabled by opti-ox technology"
  Presenter TBC
  Theme and Topic:  A.03.b. Pluripotent stem cells – Differentiation and reprogramming
  Presentation Time Mobile App: Sun., Oct. 6, 2024 8 - 9 a.m.

• "Scalable iPSC programming strategy in combination with optimised cocktails of neurotrophic factors yields functionally distinct nociceptor sensory neurons"
  Presenter TBC
  Session Number: PSTR068
  Session Title: Pain Models With a Focus on Sex Differences, Human and In Vitro Approaches
  Session Date and Time: 10/6/2024 8:00:00 AM - 10/6/2024 12:00:00 PM
  Location/Room: MCP Hall A
  Poster Board Number: C135
  Presentation Time: Sun., Oct. 6, 2024 10 - 11 a.m.
  Presentation Number: PSTR068.11